Voglimac GM 1 Hd

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)

Type 2 diabetes mellitus: to improve blood glucose control in adults when diet and exercise are insufficient; helps reduce post-meal (postprandial) and fasting blood sugar.

Voglibose is an alpha-glucosidase inhibitor that delays carbohydrate digestion and absorption in the intestine, lowering post-meal glucose spikes. Metformin (ER) reduces glucose production in the liver and improves insulin sensitivity, helping lower fasting and overall blood sugar.

Take exactly as prescribed. Usually taken with meals; voglibose works best when taken just before/with the first bite of food. Swallow the extended-release tablet whole; do not crush or chew. Regularly monitor blood glucose as advised.

Flatulence, abdominal discomfort, diarrhea, nausea, vomiting, loss of appetite, metallic taste, headache

For prescription use only. Metformin may rarely cause lactic acidosis—risk increases with severe kidney disease, dehydration, heavy alcohol use, severe infection, shock, or hypoxia; kidney function should be assessed before and during therapy. Temporarily stop metformin before/after iodinated contrast procedures and major surgery as advised by doctor. Use caution in liver disease, heart failure, and elderly. Risk of hypoglycaemia increases when used with insulin or sulfonylureas; recognize symptoms and treat promptly.

Alcohol (increases lactic acidosis risk), iodinated contrast media, insulin and sulfonylureas (increased hypoglycaemia risk), diuretics and ACE inhibitors/ARBs (may affect renal function), corticosteroids and thyroid hormones (may raise glucose), cationic drugs excreted by renal tubular secretion (e.g., cimetidine) may increase metformin levels

Store below 25°C in a dry place, protected from light and moisture. Keep in original blister pack and out of reach of children.

Voglibose+Metformin ER 0.2/1000 tablets (various brands), Vogli-M 0.2/1000 ER, Voglimet XR 0.2/1000, Voglibose Metformin SR 0.2/1000 (generic alternatives)